News 20 May 2026 - 21 May 2026

Sera Prognostics Moves Up 15% Just Ahead of Holiday
····

Sera Prognostics Moves Up 15% Just Ahead of Holiday

Sera Prognostics shares jumped 15% to $2.07 Friday, trading over 530,000 shares—21 times the previous day’s volume—despite no new company disclosures. The move outpaced peers and came as Sera reported $14,000 in Q1 revenue, a net loss of $8.4 million, and $86.8 million in cash. Executives said 2026 revenue may stay “modest and uneven” as reimbursement and awareness efforts continue.
May 23, 2026
NAII Stock Gains Despite Wider Loss, Cash Still the Focus
···

NAII Stock Gains Despite Wider Loss, Cash Still the Focus

Natural Alternatives International shares rose 1.8% to $2.59 after reporting a fiscal third-quarter loss of $4.3 million on $35.5 million in revenue. Gross margin fell to 1.1% as sales rose 23%. The company replaced Wells Fargo debt with an $11 million term loan and a $20 million working-capital line from Legacy Corporate Lending. Management plans to sell its headquarters for added liquidity.
May 21, 2026
HeartCore Cash Concerns Leave HTCR Shares Flat
···

HeartCore Cash Concerns Leave HTCR Shares Flat

HeartCore Enterprises shares closed at $2.70 Wednesday, up 2 cents, with thin volume of 23,040 shares. The company reported a 40.5% drop in quarterly revenue and an 86.4% decline in gross profit. Its 10-Q cited “substantial doubt” about its ability to continue as a going concern, with $0.8 million in cash and a $15.6 million accumulated deficit at March 31. No new corporate announcements were posted.
May 20, 2026
Sunrun Stock Jumps as Solar Names Rally; Cash Flow in the Spotlight
···

Sunrun Stock Jumps as Solar Names Rally; Cash Flow in the Spotlight

Sunrun Inc. shares closed at $13.69 Wednesday, up 3.9% on heavy volume, as solar stocks rallied broadly. First-quarter revenue rose 43% to $722.2 million, but the company reported negative Cash Generation of $59 million. Sunrun’s storage attachment rate hit a record 73%. The company warned that higher interest rates and policy changes could impact financing and costs.
May 20, 2026
Esperion Shares Flat at $3.16 as Archimed Bid Nears Endgame
···

Esperion Shares Flat at $3.16 as Archimed Bid Nears Endgame

Esperion Therapeutics shares held at $3.13 late Wednesday, just below Archimed’s $3.16-a-share cash offer, as investors assessed closing and milestone risks in the $1.1 billion take-private deal. The stock saw volume above 7 million shares. The merger includes a contingent value right tied to future drug sales. Esperion’s first-quarter revenue rose to $80.1 million, with a net loss narrowing to $25.2 million.
May 20, 2026
ARGX Stock Watch: Argenx Up Ahead of Immunovant Trial Data
···

ARGX Stock Watch: Argenx Up Ahead of Immunovant Trial Data

argenx SE shares rose 0.7% to $803.67 Wednesday, trailing biotech peers after Immunovant reported positive rheumatoid arthritis trial data for IMVT-1402, sending its stock up 35.1%. VYVGART sales reached $1.3 billion last quarter. The FDA recently expanded VYVGART’s approval for generalized myasthenia gravis. argenx’s next key data releases are expected later this year.
May 20, 2026
Ituran Shares Tick Higher Ahead of Results
···

Ituran Shares Tick Higher Ahead of Results

Ituran Location and Control shares rose 0.39% to $57.17 on Nasdaq Wednesday, ahead of its first-quarter results due May 26. The company, valued at $1.14 billion, last reported quarterly revenue of $93.5 million and 77 cents EPS, with 76% of revenue from subscriptions. Analyst targets range from $55 to $70. The stock remains below its 52-week high of $62.31.
May 20, 2026
First Watch shares steady as growth put to the test
···

First Watch shares steady as growth put to the test

First Watch shares rose 0.5% to $10.94 Wednesday afternoon, lagging a broader small-cap rally. The company’s annual meeting was set for Wednesday morning, with director elections and pay votes on the agenda. Quarterly results showed revenue up 17% to $331 million, but guest traffic fell 2% and the company posted a $2.7 million net loss.
May 20, 2026
Fifth Era Stock Little Changed as Traders Watch $10 Billion Metals Deal
···

Fifth Era Stock Little Changed as Traders Watch $10 Billion Metals Deal

Fifth Era Acquisition Corp I Class A shares traded at $10.37, down 0.1% in thin Nasdaq trading Wednesday, near the $10.43 per-share trust value reported March 31. The SPAC expects to close its merger with strategic metals firm Miotal in the second half of 2026, pending approvals. CFO Christopher Linn resigned May 8, replaced by Christopher Nelson. Fifth Era reported $1.29 million net income for the March quarter, with no operating revenue.
May 20, 2026
Immutep Shares Drop as Investors Face Trial Setback, Lawsuit Date and Nasdaq Alert
···

Immutep Shares Drop as Investors Face Trial Setback, Lawsuit Date and Nasdaq Alert

Immutep Ltd’s Nasdaq ADRs fell about 5% Wednesday as new law-firm notices highlighted litigation over its failed lung-cancer trial. The stock traded at $0.4778, below the $1 minimum required by Nasdaq, which warned the company on April 30. A securities class-action lawsuit was filed covering ADR purchases from March 2025 to March 2026. Immutep reported A$110.6 million in cash at March 31.
May 20, 2026
Krispy Kreme Stock Pops as DNUT’s Turnaround Faces Its Next Test
···

Krispy Kreme Stock Pops as DNUT’s Turnaround Faces Its Next Test

Krispy Kreme shares climbed 4.4% to $3.35 Wednesday, outpacing major indexes as McDonald’s traded flat. The company reported first-quarter net revenue of $367 million, down 2.2%, with a narrowed net loss of $22.7 million and adjusted EBITDA up 38% to $33.1 million. Krispy Kreme ended Q1 with 15,125 global points of access, down 15.9% from a year earlier. Recent promotions included free doughnuts for graduates and the return of a lemon-filled item.
May 20, 2026
Oportun Shares Gain on Profit Run, Questions Remain Around Credit Losses
···

Oportun Shares Gain on Profit Run, Questions Remain Around Credit Losses

Oportun Financial shares rose 2.9% to $5.40 Wednesday afternoon, near their intraday high, on volume of about 191,000 shares and no recent company news. Peer lenders and small-cap benchmarks also gained. Oportun’s latest filings show first-quarter net income of $2.3 million and a net charge-off rate rising to 12.7%. The company plans a new credit model and risk-based pricing as delinquency rates edge down.
May 20, 2026
Toro Stock Edges Up Before Dividend Cutoff
···

Toro Stock Edges Up Before Dividend Cutoff

Toro Corp shares rose 9 cents to $5.30 in light Nasdaq trading Wednesday, ahead of Friday’s deadline for investors to elect a $0.90 special dividend in stock or cash. The company, which operates LPG and MR tankers, may still pay the dividend entirely in cash. Volume reached 36,848 shares. Toro reported $87.4 million in cash at year-end, with 2025 vessel revenue down 5.8% to $21.1 million.
May 20, 2026
1 … 7 8 9 10 11 … 337

Stock Market Today

  • 3 ASX Dividend Shares Yielding Up to 9% With Monthly Payouts
    May 22, 2026, 8:02 PM EDT. Three ASX-listed dividend shares offering monthly payouts are attracting income-focused investors seeking steady passive income. BetaShares Australian Top 20 Equity Yield Maximiser Fund (ASX: YMAX) delivers a 9% gross distribution yield, mainly invested in financials and materials sectors. Plato Income Maximiser Ltd (ASX: PL8), a listed investment company, pays fully-franked monthly dividends with a 4.8% yield, focusing on major ASX dividend stocks. Metrics Income Opportunities Trust (ASX: MOT), a listed investment trust investing in private credit and related assets, targets a 7% cash yield, offering monthly income and capital preservation. These options provide diversified income streams with frequent payouts for investors prioritizing regular cash flow.